208 related articles for article (PubMed ID: 12524233)
1. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy.
Hegele RA; Kraw ME; Ban MR; Miskie BA; Huff MW; Cao H
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):111-6. PubMed ID: 12524233
[TBL] [Abstract][Full Text] [Related]
2. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.
Hegele RA; Anderson CM; Wang J; Jones DC; Cao H
Genome Res; 2000 May; 10(5):652-8. PubMed ID: 10810087
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
4. Premature atherosclerosis associated with monogenic insulin resistance.
Hegele RA
Circulation; 2001 May; 103(18):2225-9. PubMed ID: 11342468
[TBL] [Abstract][Full Text] [Related]
5. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
6. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.
Haque WA; Oral EA; Dietz K; Bowcock AM; Agarwal AK; Garg A
Diabetes Care; 2003 May; 26(5):1350-5. PubMed ID: 12716787
[TBL] [Abstract][Full Text] [Related]
9. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM
Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
[TBL] [Abstract][Full Text] [Related]
11. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome.
Hegele RA
Mol Genet Metab; 2000 Dec; 71(4):539-44. PubMed ID: 11136544
[TBL] [Abstract][Full Text] [Related]
12. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration.
Hegele RA; Cao H; Huff MW; Anderson CM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3089-93. PubMed ID: 10999791
[TBL] [Abstract][Full Text] [Related]
13. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation.
Araújo-Vilar D; Loidi L; Domínguez F; Cabezas-Cerrato J
Horm Metab Res; 2003 Jan; 35(1):29-35. PubMed ID: 12669268
[TBL] [Abstract][Full Text] [Related]
15. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
[TBL] [Abstract][Full Text] [Related]
16. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
[TBL] [Abstract][Full Text] [Related]
17. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.
Cao H; Hegele RA
Hum Mol Genet; 2000 Jan; 9(1):109-12. PubMed ID: 10587585
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
[TBL] [Abstract][Full Text] [Related]
19. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
[TBL] [Abstract][Full Text] [Related]
20. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]